Wang Lihua, Wei Fang, Sun Guijiang, Chen Haiyan, Yu Haibo, Jiang Aili
Department of Kidney Disease and Blood Purification Centre, Institute of Urology and Key Laboratory of Tianjin, 2nd Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
, 23rd, Pingjiang Road, Hexi District, Tianjin, 300211, People's Republic of China.
J Nephrol. 2016 Feb;29(1):105-10. doi: 10.1007/s40620-015-0198-9. Epub 2015 May 13.
Until now, the survival of iliac vein tunneled cuffed catheters (TCCs) used in elderly patients has not been fully investigated. Accordingly, we evaluated their use in elderly hemodialysis patients with no other venous access options.
A total of 70 elderly patients with iliac vein TCCs undergoing chronic hemodialysis were included in this study. Patients' baseline anthropometric and laboratory parameters were measured. Incidence of catheter dysfunction and of catheter-related infection was documented.
During the study period, a total of 99 new tunneled dialysis catheters were placed. Technical success rate was 100 %. Median infection-free survival and dysfunction-free survival after catheterization was 617 and 875 catheter days, respectively. Mean survival time per catheter was 1067 catheter days, corresponding to a total observation period of 65369 catheters days.
Iliac TCC is both technically feasible and effective for hemodialysis in elderly patients with no other venous access options.
迄今为止，老年患者使用的髂静脉带隧道带涤纶套中心静脉导管（TCC）的留存情况尚未得到充分研究。因此，我们评估了在没有其他静脉通路选择的老年血液透析患者中使用该导管的情况。
本研究纳入了70例接受慢性血液透析的使用髂静脉TCC的老年患者。测量患者的基线人体测量学和实验室参数。记录导管功能障碍和导管相关感染的发生率。
在研究期间，共置入了99根新的带隧道透析导管。技术成功率为100%。置管后无感染存活期和无功能障碍存活期的中位数分别为617和875导管日。每根导管的平均存活时间为1067导管日，相当于65369导管日的总观察期。
对于没有其他静脉通路选择的老年患者，髂静脉TCC用于血液透析在技术上是可行且有效的。
